Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
226 Leser
Artikel bewerten:
(0)

Upsher-Smith Named Healthcare Distribution Management Association's Manufacturer Partner of the Year

MAPLE GROVE, Minn., June 9, 2014 /PRNewswire/ --Upsher-Smith Laboratories, Inc. today announced that it is the recipient of a Distribution Industry Award for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with one of the two "2014 DIANA Manufacturer Partner of the Year" awards. The Company was also recognized as aMerit Finalist for the "Best Overall Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $300 Million." The HDMA recognized leading pharmaceutical and consumer product manufacturers with the presentation of 10 DIANA Awards at its 2014 Business and Leadership Conference in Phoenix, Arizona on June 2, 2014.

Upsher-Smith DIANA Award Presentation; Left to Right: John Gray (President & CEO, HDMA), Brad Leonard (Director of National Accounts, Upsher-Smith), Jim Maahs (Sr. Director, Commercial Operations, Upsher-Smith), David Neu (President, AmeriSourceBergen Drug Corp).

For more than 50 years, the DIANA Awards have been presented to healthcare and consumer product manufacturers that set the standard for excellence in new product introductions and promotions. DIANA winners are chosen by HDMA distributor members who judge companies based on several criteria including: knowledgeable salespeople, high-level customer service, demonstrated flexibility and creativity in marketing, and incorporation of new technologies to ensure product safety and security. Upsher-Smith is included among a distinguished group of past recipients who serve as models for leadership and innovation in the healthcare marketplace.

"We are honored to be one of the select companies recognized by HDMA members for this prestigious DIANA Award," said Scott Hussey, Sr. Vice President, Sales, Upsher-Smith Laboratories, Inc."At Upsher-Smith we strive to be an outcomes-driven partner in healthcare and to deliver high-quality, high-value products to patients. We would like to thank the HDMA members for their recognition, and for naming Upsher-Smith Partner of the Year."

About Upsher-Smith

Upsher-Smith Laboratories, Inc., founded in 1919, is a growing pharmaceutical company dedicated to its mission of Advancing Pharmacotherapy. Improving Life'. With capabilities ranging from early-stage research to delivering on-market products, Upsher-Smith is committed to offering quality products that enable people to live life to its greatest potential. Upsher-Smith's approach to product development and partnering has resulted in a broad range of both branded and generic therapeutic solutions to address patients' needs. The Company has a particular focus on developing therapies for people living with central nervous system (CNS) conditions, such as seizure disorders, and has a robust pipeline of promising CNS compounds in various stages of development. For more information, visit www.upsher-smith.com.

About HDMA

HDMA is the national association representing primary healthcare distributors, the vital link between the nation's pharmaceutical manufacturers and healthcare providers. Each business day, HDMA member companies ensure that 15 million prescription medicines and healthcare products are delivered safely and efficiently to nearly 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDMA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation's healthcare system.

Upsher-Smith Laboratories, Inc.

Photo - http://photos.prnewswire.com/prnh/20140609/116229

Logo- http://photos.prnewswire.com/prnh/20130520/NY17281LOGO

SOURCE Upsher-Smith Laboratories, Inc.

© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.